Serum levels of CXCL13 are associated with ultrasonographic synovitis and predict power Doppler persistence in early rheumatoid arthritis treated with non-biological disease-modifying anti-rheumatic drugs

Should imaging be a component of rheumatoid arthritis remission criteria? A comparison between traditional and modified composite remission scores and imaging assessments

(2011) B. Saleem et al.   ANNALS OF THE RHEUMATIC DISEASES

Identification of CXCL13 as a marker for rheumatoid arthritis outcome using an in silico model of the rheumatic joint

(2011) Cees M. Meeuwisse et al.   ARTHRITIS AND RHEUMATISM

CXCL13/CXCR5 signaling enhances BCR-triggered B-cell activation by shaping cell dynamics

(2011) J. Saez de Guinoa et al.   BLOOD

CXCR5 Expressing Human Central Memory CD4 T Cells and Their Relevance for Humoral Immune Responses

(2011) N. Chevalier et al.   JOURNAL OF IMMUNOLOGY

Subclinical remodelling of draining lymph node structure in early and established rheumatoid arthritis assessed by power Doppler ultrasonography

(2011) A. Manzo et al.   RHEUMATOLOGY

Synovial Tissue Heterogeneity and Peripheral Blood Biomarkers

(2011) Serena Bugatti et al.   Current Rheumatology Reports

Early disease control by low-dose prednisone comedication may affect the quality of remission in patients with early rheumatoid arthritis

(2010) Monica Todoerti et al.   Annals of the New York Academy of Sciences

Current evidence for a strategic approach to the management of rheumatoid arthritis with disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis

(2010) R. Knevel et al.   ANNALS OF THE RHEUMATIC DISEASES

Treating rheumatoid arthritis to target: recommendations of an international task force

(2010) J. S. Smolen et al.   ANNALS OF THE RHEUMATIC DISEASES

CXCL13: a novel biomarker of B-cell return following rituximab treatment and synovitis in patients with rheumatoid arthritis

(2010) S. Rosengren et al.   RHEUMATOLOGY

Predicting arthritis outcomes--what can be learned from the Leiden Early Arthritis Clinic?

(2010) D. P. C. de Rooy et al.   RHEUMATOLOGY

Time to achieve remission determines time to be in remission

(2010) Lydia G Schipper et al.   ARTHRITIS RESEARCH & THERAPY

Antibodies to citrullinated proteins in arthritis: pathology and promise

(2009) Lars Klareskog et al.   CURRENT OPINION IN RHEUMATOLOGY

Secondary and ectopic lymphoid tissue responses in rheumatoid arthritis: from inflammation to autoimmunity and tissue damage/remodeling

(2009) Antonio Manzo et al.   IMMUNOLOGICAL REVIEWS

Proposal for Levels of Evidence Schema for Validation of a Soluble Biomarker Reflecting Damage Endpoints in Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis, and Recommendations for Study Design

(2009) W. P. MAKSYMOWYCH et al.   JOURNAL OF RHEUMATOLOGY

Ultrasonographic evaluation of joint involvement in early rheumatoid arthritis in clinical remission: power Doppler signal predicts short-term relapse

(2009) C. A. Scire et al.   RHEUMATOLOGY

Power doppler ultrasonographic monitoring of response to anti-tumor necrosis factor therapy in patients with rheumatoid arthritis

(2008) Esperanza Naredo et al.   ARTHRITIS AND RHEUMATISM

Mature antigen-experienced T helper cells synthesize and secrete the B cell chemoattractant CXCL13 in the inflammatory environment of the rheumatoid joint

(2008) Antonio Manzo et al.   ARTHRITIS AND RHEUMATISM

Potential novel biomarkers of disease activity in rheumatoid arthritis patients: CXCL13, CCL23, transforming growth factor α, tumor necrosis factor receptor superfamily member 9, and macrophage colony-stimulating factor

(2008) Inmaculada Rioja et al.   ARTHRITIS AND RHEUMATISM

An explanation for the apparent dissociation between clinical remission and continued structural deterioration in rheumatoid arthritis

(2008) A. K. Brown et al.   ARTHRITIS AND RHEUMATISM